Medtronic Long-Term Debt increased by 0.7% to $27.88B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.2%, from $23.99B to $27.88B. Over 4 years (FY 2021 to FY 2025), Long-Term Debt shows a downward trend with a -2.7% CAGR.
An increase indicates higher financial leverage, which can amplify returns on equity but also increases interest expense and financial risk.
Loans and financial obligations with a maturity period exceeding one year, typically consisting of corporate bonds and n...
Capital-intensive firms or those with aggressive share buyback programs often carry higher long-term debt than asset-light competitors.
long_term_debt| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.20B | $28.00B | $26.50B | $20.37B | $20.10B | $21.10B | $22.21B | $24.34B | $24.46B | $23.74B | $24.15B | $23.93B | $26.31B | $24.61B | $23.99B | $25.64B | $26.18B | $27.68B | $27.88B |
| QoQ Change | — | -4.1% | -5.4% | -23.1% | -1.3% | +5.0% | +5.3% | +9.6% | +0.5% | -3.0% | +1.7% | -0.9% | +9.9% | -6.5% | -2.5% | +6.9% | +2.1% | +5.7% | +0.7% |
| YoY Change | — | — | — | — | -31.2% | -24.6% | -16.2% | +19.5% | +21.7% | +12.5% | +8.7% | -1.7% | +7.6% | +3.6% | -0.7% | +7.1% | -0.5% | +12.5% | +16.2% |